Publication Name	World Journal of Clinical Cases
Manuscript ID	59240
Country	China

Category	Infectious Diseases
Manuscript Type	Retrospective Cohort Study
Article Title	Angiotensin converting enzymes inhibitors or angiotensin receptor blockers should be continued in COVID-19 patients with hypertension
Manuscript Source	Unsolicited Manuscript
All Author List	Ci Tian, Nan Li, Yi Bai, Han Xiao, Shu Li, Qing-Gang Ge, Ning Shen and Qing-Bian Ma
Funding Agency and Grant Number
Corresponding Author	Qing-Bian Ma, MD, Associate Professor, Chairman, Chief Physician, Department of Emergency Medicine, Peking University Third Hospital, No. 49 North Garden Road, Haidian District, Beijing 100191, China. maqingbian@bjmu.edu.cn
Key Words	COVID-19; Hypertension; Angiotensin converting enzymes inhibitors; Angiotensin receptor blockers; Angiotensin-converting enzyme-2; Prognosis
Core Tip	Recent research revealed that the ingestion of angiotensin converting enzymes inhibitors or angiotensin receptor blockers (ACEIs/ARBs) had no significant harm on coronavirus disease 2019 (COVID-19) patients complicated with hypertension. However, the impact of discontinue using ACEIs/ARBs in those patients was still unclearly. In the present study, we retrospectively collected the clinical data of patients with both COVID-19 and hypertension, and to explore whether any difference in disease outcomes occurred between patients who discontinued using ACEIs/ARBs and those who continued using other anti-hypertensive drugs.
Citation	Tian C, Li N, Bai Y, Xiao H, Li S, Ge QG, Shen N, Ma QB. Angiotensin converting enzymes inhibitors or angiotensin receptor blockers should be continued in COVID-19 patients with hypertension. World J Clin Cases 2021; 9(1): 47-60

Received	2020-10-09 09:17
Peer-Review Started	2020-10-09 09:17
To Make the First Decision
Return for Revision	2020-11-03 00:39
Revised	2020-11-09 07:59
Second Decision	2020-11-16 11:29
Accepted by Journal Editor-in-Chief
Accepted by Company Editor-in-Chief	2020-11-21 05:47
Articles in Press	2020-11-21 05:47
Publication Fee Transferred
Edit the Manuscript by Language Editor	2020-11-26 23:01
Typeset the Manuscript	2020-12-28 15:12

ISSN	2307-8960 (online)
Open Access	This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/
Copyright	© The Author(s) 2020. Published by Baishideng Publishing Group Inc. All rights reserved.
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com